Free Trial

BILL (NYSE:BILL) Stock Gets Price Target Boost from Oppenheimer

BILL logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Oppenheimer raised BILL’s price target from $55 to $60 and maintained an “outperform” rating, implying 13.2% upside from the prior close.
  • Analyst sentiment is broadly positive: BILL has a “Moderate Buy” consensus rating and an average target price of $59.06.
  • Quarterly adjusted EPS of $1.18 beat estimates of $0.98, but revenue of $353.77 million missed expectations and declined 10.6% year over year.
  • Interested in BILL? Here are five stocks we like better.

BILL (NYSE:BILL - Get Free Report) had its target price upped by Oppenheimer from $55.00 to $60.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an "outperform" rating on the stock. Oppenheimer's price objective suggests a potential upside of 13.21% from the stock's previous close.

A number of other research firms have also recently issued reports on BILL. Morgan Stanley upped their price objective on shares of BILL from $55.00 to $60.00 and gave the stock an "equal weight" rating in a research report on Thursday, August 20th. Wall Street Zen upgraded shares of BILL from a "hold" rating to a "buy" rating in a research report on Saturday, August 22nd. Jefferies Financial Group lowered shares of BILL from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 28th. Keefe, Bruyette & Woods boosted their target price on shares of BILL from $52.00 to $58.00 and gave the stock a "market perform" rating in a research note on Friday. Finally, Weiss Ratings downgraded shares of BILL from a "sell (d+)" rating to a "sell (d)" rating in a report on Monday, August 31st. Eleven investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, BILL presently has a consensus rating of "Moderate Buy" and a consensus target price of $59.06.

Read Our Latest Stock Analysis on BILL

BILL Price Performance

Shares of BILL traded up $2.11 during midday trading on Friday, hitting $53.00. The company's stock had a trading volume of 861,320 shares, compared to its average volume of 2,381,804. BILL has a one year low of $31.41 and a one year high of $57.21. The company's fifty day simple moving average is $47.19 and its two-hundred day simple moving average is $42.67. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $4.55 billion, a price-to-earnings ratio of -408.77, a price-to-earnings-growth ratio of 0.75 and a beta of 1.08.

BILL (NYSE:BILL - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $1.18 EPS for the quarter, topping analysts' consensus estimates of $0.98 by $0.20. BILL had a positive return on equity of 3.74% and a negative net margin of 0.68%. The company had revenue of $353.77 million during the quarter, compared to analysts' expectations of $438.62 million. During the same quarter in the previous year, the firm earned $0.61 EPS. BILL's revenue was down 10.6% on a year-over-year basis. BILL has set its FY 2027 guidance at 3.990-4.150 EPS and its Q2 2027 guidance at 0.970-1.010 EPS. As a group, equities analysts expect that BILL will post 2.29 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Michael Cieri sold 10,754 shares of the business's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $49.13, for a total transaction of $528,344.02. Following the sale, the insider directly owned 997 shares in the company, valued at approximately $48,982.61. The trade was a 91.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Rene Lacerte sold 42,248 shares of the company's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $50.17, for a total value of $2,119,582.16. Following the completion of the transaction, the chief executive officer directly owned 163,125 shares of the company's stock, valued at $8,183,981.25. This represents a 20.57% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 267,997 shares of company stock worth $13,057,984. Company insiders own 13.20% of the company's stock.

Institutional Investors Weigh In On BILL

Institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP raised its stake in BILL by 4.3% during the first quarter. Dimensional Fund Advisors LP now owns 3,090,741 shares of the company's stock worth $118,366,000 after buying an additional 126,427 shares during the last quarter. Sepio Capital LP boosted its position in BILL by 1,251.6% during the third quarter. Sepio Capital LP now owns 1,304,267 shares of the company's stock valued at $55,484,000 after acquiring an additional 1,207,769 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new stake in BILL during the third quarter valued at $35,983,000. Canada Pension Plan Investment Board bought a new stake in BILL during the second quarter valued at $14,894,000. Finally, Algert Global LLC grew its holdings in BILL by 113.8% during the 2nd quarter. Algert Global LLC now owns 385,264 shares of the company's stock worth $13,931,000 after acquiring an additional 205,024 shares during the period. 97.99% of the stock is owned by institutional investors.

More BILL News

Here are the key news stories impacting BILL this week:

  • Positive Sentiment: Adjusted EPS was $1.18, beating the $0.98 consensus and rising from $0.61 a year earlier. The company also highlighted margin discipline, accelerating AI adoption, new product launches and improving payment monetization on its earnings call. BILL Q1 Earnings Call Highlights AI Push and Margin Discipline
  • Positive Sentiment: Fiscal 2027 EPS guidance of $3.99–$4.15 is above the $3.44 analyst consensus. Q2 EPS guidance of $0.97–$1.01 also exceeds the $0.82 consensus, suggesting the company expects earnings to hold up despite revenue pressure. BILL Reports First Quarter Fiscal Year 2027 Financial Results
  • Neutral Sentiment: Keefe, Bruyette & Woods raised its price target from $52 to $58 but kept a “market perform” rating, a modestly more constructive valuation view without an upgrade in its recommendation. Keefe, Bruyette & Woods stock recommendations
  • Negative Sentiment: Revenue was $353.77 million, well below the $438.62 million consensus and down 10.6% year over year. The outlook also signals a sizeable revenue shortfall: fiscal 2027 guidance of $1.4–$1.5 billion compares with $1.8 billion expected, while Q2 revenue guidance of $353–$363 million is below the $453.1 million consensus. This weakness could temper optimism about the earnings beat. BILL quarterly earnings report

About BILL

(Get Free Report)

BILL Holdings, Inc provides financial operations software for small and midsize businesses, accountants and financial institutions. Its cloud-based platform is designed to automate and simplify back-office processes, including accounts payable, accounts receivable, expense management, budgeting and payments.

The company's offerings enable businesses to receive and pay bills, send invoices, manage expenses, establish spending controls and connect financial workflows with accounting systems.

Featured Articles

Analyst Recommendations for BILL (NYSE:BILL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BILL Right Now?

Before you consider BILL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BILL wasn't on the list.

While BILL currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines